Almirall S.A. (LBTSF)
PNK: LBTSF
· Real-Time Price · USD
9.01
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 9.01 |
| Market Cap | 1.92B |
| Revenue (ttm) | 985.72M |
| Net Income (ttm) | 10.15M |
| EPS (ttm) | 0.06 |
| PE Ratio (ttm) | 150.17 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 9.01 |
| Volume | 10 |
| Avg. Volume (20D) | 1 |
| Open | 9.75 |
| Previous Close | 9.01 |
| Day's Range | 9.01 - 9.75 |
| 52-Week Range | 9.01 - 9.75 |
| Beta | 0.31 |
About LBTSF
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respirato...
Sector Healthcare
IPO Date Aug 3, 2012
Employees 2,026
Stock Exchange PNK
Ticker Symbol LBTSF
Website https://www.almirall.com
2 months ago · seekingalpha.com
Almiralll, S.A. (LBTSF) Q4 2024 Earnings Call TranscriptAlmiralll, S.A. (LBTSF) Q4 2024 Earnings Call Transcript